{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:25:47Z","timestamp":1788456347723,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CVIR Endovasc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Obsidio conformable embolic (OCE, Boston Scientific, MA) is a novel, radiopaque and conformable embolic. The purpose of this report is to describe its use for treatment of acute intra-abdominal hemorrhages.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and results<\/jats:title>\n                <jats:p>Three patients presented with acute hemorrhage and were treated with OCE, including post-paracentesis hemorrhage, penetrating trauma to the liver, and blunt trauma in the spleen. All cases were performed under moderate sedation, with hemostasis achieved by end of procedure using less than 1 vial of OCE (0.2-0.4\u00a0ml). No severe adverse events occurred. None required repeated treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Short conclusion<\/jats:title>\n                <jats:p>OCE is a safe and effective embolic agent for treatment of intra-abdominal or visceral hemorrhage. Future studies with larger sample sizes and longer follow-up are warranted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42155-024-00492-0","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T07:02:20Z","timestamp":1730876540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A novel conformable embolic for selective transarterial embolization of acute hemorrhages: a technical note"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9774-9226","authenticated-orcid":false,"given":"Qian","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuf","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Funaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikin","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"issue":"4","key":"492_CR1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1055\/s-0029-1242206","volume":"26","author":"M Lubarsky","year":"2009","unstructured":"Lubarsky M, Ray CE, Funaki B. Embolization agents-which one should be used when? Part 1: large-vessel embolization. Semin Intervent Radiol. 2009;26(4):352\u20137.","journal-title":"Semin Intervent Radiol"},{"issue":"5","key":"492_CR2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/gels9050378","volume":"9","author":"A Pal","year":"2023","unstructured":"Pal A, et al. Liquid Embolic Agents for Endovascular Embolization: A Review. Gels. 2023;9(5):378.","journal-title":"Gels."},{"issue":"1","key":"492_CR3","doi-asserted-by":"publisher","first-page":"2003327","DOI":"10.1002\/advs.202003327","volume":"8","author":"H Albadawi","year":"2021","unstructured":"Albadawi H, et al. Nanocomposite Hydrogel with Tantalum Microparticles for Rapid Endovascular Hemostasis. Adv Sci. 2021;8(1):2003327.","journal-title":"Adv Sci"},{"key":"492_CR4","doi-asserted-by":"crossref","unstructured":"Avery RK, et al. An injectable shear-thinning biomaterial for endovascular embolization. Sci Transl Med.\u00a02016;8(365):365ra156.","DOI":"10.1126\/scitranslmed.aah5533"},{"issue":"33","key":"492_CR5","doi-asserted-by":"publisher","first-page":"1901071","DOI":"10.1002\/adma.201901071","volume":"31","author":"J Hu","year":"2019","unstructured":"Hu J, et al. Advances in biomaterials and technologies for vascular embolization. Adv Mater. 2019;31(33):1901071.","journal-title":"Adv Mater"},{"issue":"2","key":"492_CR6","doi-asserted-by":"publisher","first-page":"2106865","DOI":"10.1002\/adma.202106865","volume":"34","author":"J Hu","year":"2022","unstructured":"Hu J, et al. Silk embolic material for catheter-directed endovascular drug delivery. Adv Mater. 2022;34(2):2106865.","journal-title":"Adv Mater"},{"key":"492_CR7","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00270-017-1703-4","volume":"40","author":"D Filippiadis","year":"2017","unstructured":"Filippiadis D, et al. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Interv Radiol. 2017;40:1141\u20136.","journal-title":"Cardiovasc Interv Radiol"},{"key":"492_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jconrel.2016.02.033","volume":"240","author":"A Poursaid","year":"2016","unstructured":"Poursaid A, et al. Polymeric materials for embolic and chemoembolic applications. J Controlled Release. 2016;240:414\u201333.","journal-title":"J Controlled Release"},{"issue":"2","key":"492_CR9","first-page":"98","volume":"24","author":"H Hill","year":"2018","unstructured":"Hill H, et al. N-butyl cyanoacrylate embolotherapy: techniques, complications, and management. Diagn Interventional Radiol. 2018;24(2):98.","journal-title":"Diagn Interventional Radiol"},{"issue":"8","key":"492_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s11604-014-0328-7","volume":"32","author":"Y Takeuchi","year":"2014","unstructured":"Takeuchi Y, Morishita H, Sato Y, Hamaguchi S, Sakamoto N, Tokue H, Yonemitsu T, Murakami K, Fujiwara H, Sofue K, Abe T. Guidelines for the use of NBCA in vascular embolization devised by the Committee of Practice Guidelines of the Japanese Society of Interventional Radiology (CGJSIR), 2012 edition. Jpn J Radiol. 2014;32(8):500\u201317.","journal-title":"Jpn J Radiol"}],"container-title":["CVIR Endovascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-024-00492-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42155-024-00492-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-024-00492-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T07:02:23Z","timestamp":1730876543000},"score":1,"resource":{"primary":{"URL":"https:\/\/CVIRendovasc.springeropen.com\/articles\/10.1186\/s42155-024-00492-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["492"],"URL":"https:\/\/doi.org\/10.1186\/s42155-024-00492-0","relation":{},"ISSN":["2520-8934"],"issn-type":[{"value":"2520-8934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}